Direktorat Registrasi ObatValid

SITAGLIPTIN PHOSPHATE MONOHYDRATE

Claim this product
BPOM Number
GKL2531412617A1
Approved
5 December 2025
Expiry
4 December 2030
Form
TABLET SALUT SELAPUT

About This Registration

SITAGLIPTIN PHOSPHATE MONOHYDRATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2531412617A1. Its current registration status is Valid, with the licence valid until 4 December 2030. The product is registered to LLOYD PHARMA INDONESIA - INDONESIA. BPOM first approved this registration in December 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, 3 STRIP @ 10 TABLET SALUT SELAPUT
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

SITAGLIPTIN PHOSPHATE

Market Intelligence

Owner Portfolio
LLOYD PHARMA INDONESIA - INDONESIA holds 52 BPOM registrations
Manufacturer Scale
LLOYD PHARMA INDONESIA - INDONESIA produces 52 registered products
Registration Age
Registered for 7 months

FDA Cross-Reference

via openFDA
Generic Name
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1